SEC Company Response from BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883) (BCLI) — Aug 6, 2013
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883)
Date: Aug. 6, 2013 · CIK: 0001137883 · Accession: 0001144204-13-043355
AI Filing Summary & Sentiment
File numbers found in text: 333-186516
Show Raw Text
CORRESP
1
filename1.htm
Roth Capital Partners, LLC
Maxim Group LLC
888 San Clemente Drive
405 Lexington Avenue, 2nd Floor
Newport Beach, CA 92660
New York, NY 10174
August 6, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Brainstorm Cell Therapeutics Inc. (the “Company”)
Registration Statement on Form S-1
(File No. 333-186516)
Ladies and Gentlemen:
In connection with the above-captioned
registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned
hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 4:00 p.m. (New
York Time) on Thursday, August 8, 2013, or as soon thereafter as practicable.
In making this request the undersigned
acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to
the registration statement.
Very truly yours,
Roth Capital Partners, LLC
MAXIM GROUP LLC
By:
/s/ Aaron Gurewitz
By:
/s/ Eric Cheng
Name:
Aaron Gurewitz
Name:
Eric Cheng
Title:
Head of Equity Capital Markets
Title:
Managing Director